A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Active, not recruiting · Phase 3 · NCT06003426
Conditions: Idiopathic Pulmonary Fibrosis
At a glance
- Research payments reported, 2025
- $274,406
- U.S. investigators named
- 23
- Sites paid
- 16
- Planned or actual enrollment
- 1,255
About the trial
- Sponsor
- Bristol-Myers Squibb
- Tested
- BMS-986278 (drug), BMS-986278 Placebo (drug)
- Dates
- Started 2023-09-14; completion 2027-06-04
- Results posted
- Not yet
The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis.
From ClinicalTrials.gov, last updated 2026-03-24. Full record, eligibility and contacts (opens in a new tab)
Industry funding
E.r. Squibb & Sons, L.l.c. reported $274,406 in research payments for this study in 2025 (23 payments).
Products named: Sotyktu
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Lindsay S. Ackerman, MD Dermatology · Phoenix, AZ
- Vivian Laquer, M.D. Dermatology · Irvine, CA
- Howard L. Sofen, M.D. Dermatology · Los Angeles, CA
- Aliuska Alvarez, MD Neurology · Miami, FL
- Gelasio A. Baras Pier, M.D Neurology · Miami, FL
- Jose Delagandara, M.D. Specialist · West Palm Beach, FL
- Belkis Delgado, M.D. Internal Medicine · Miami Springs, FL
- Jose E. Gamez, M.D Psychiatry · Hialeah, FL
- Stephanie Mehlis, M.D. Dermatology · Skokie, IL
- Scott A. Fretzin, M.D. Dermatology · Indianapolis, IN
- Scott T. Guenthner, MD Dermatology · Greenwood, IN
- Benjamin N. Lockshin, MD Dermatology · Silver Spring, MD
- Linda F. Stein Gold, M.D. Dermatology · West Bloomfield, MI
- Eric J. Carbonell, M.D. Psychiatry · Festus, MO
- Steven R. Feldman, MD Dermatology · Winston Salem, NC
- Jerry Bagel, MD Dermatology · East Windsor, NJ
- Marc L. Gordon, MD Neurology · Great Neck, NY
- Alice B. Gottlieb, M.D. Dermatology · Somers, NY
- Orit Markowitz Dermatology · New York, NY
- Neil S. Sadick, M.D. Dermatology · New York, NY
- Patrick L. Shannon, M.D. Specialist · Boardman, OH
- Timothy Patton Specialist · Pittsburgh, PA
- David Pariser, M.D. Dermatology · Norfolk, VA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- The Indiana Clinical Trials Center $51,880
- Schweiger Dermatology and Allergy East Windsor $25,700
- Southwest Skin Specialists Llc $25,236
- Sadick Dermatology Research Group $25,153
- Wake Forest University Health Sciences $20,713
- Northshore University Healthsystem - Evanston Hospital, IL $17,043
- First Oc Dermatology $15,650
- Mount Sinai School of Medicine $15,540
- Advarra $14,640
- Virginia Clinical Research, Inc $12,978
- Optiskin $10,900
- University of Pittsburgh Physicians $9,054
- Dawes Fretzin Clinical Research Group, Llc $7,627
- Dermassociates $7,500
- Henry Ford Health Hospital, MI $7,492
- Dermatology Research Associates Howard Sofen MD $7,300
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.